Jason spent over 30 years in Biotechnology and has played a critical role in the innovation and expansion of cell and gene therapy. Previously, Jason held various senior leadership roles in business development, operations, M&A, Strategic Alliances, and capital project management at Becton Dickinson, Miltenyi Biotec, Rentschler Bio, Lonza Biologics, and most recently as SVP at AGC Bio.
2022 - present